Gamco Investors INC. ET AL Sells 18,802 Shares of Xylem Inc. $XYL

Gamco Investors INC. ET AL trimmed its position in Xylem Inc. (NYSE:XYL) by 5.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 351,452 shares of the industrial products company’s stock after selling 18,802 shares during the quarter. Gamco Investors INC. ET AL owned approximately 0.14% of Xylem worth $51,839,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. AQR Capital Management LLC lifted its position in Xylem by 14.4% in the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after buying an additional 3,900 shares during the last quarter. NewEdge Advisors LLC boosted its position in Xylem by 3.3% during the first quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after buying an additional 132 shares during the period. Empowered Funds LLC boosted its position in Xylem by 56.1% during the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after buying an additional 3,120 shares during the period. Y Intercept Hong Kong Ltd bought a new position in shares of Xylem during the second quarter valued at about $354,000. Finally, Assetmark Inc. increased its holdings in shares of Xylem by 379.7% in the second quarter. Assetmark Inc. now owns 921 shares of the industrial products company’s stock worth $119,000 after buying an additional 729 shares during the period. 87.96% of the stock is owned by institutional investors.

Xylem Stock Down 2.4%

Shares of NYSE:XYL opened at $123.16 on Friday. The stock’s 50-day moving average is $135.51 and its 200 day moving average is $140.61. The company has a market cap of $29.95 billion, a PE ratio of 31.42, a P/E/G ratio of 1.81 and a beta of 1.17. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.62 and a quick ratio of 1.28. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, hitting the consensus estimate of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.18 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Sell-side analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.

Xylem declared that its Board of Directors has approved a stock buyback program on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s management believes its shares are undervalued.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Tuesday, February 24th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Tuesday, February 24th. This is a positive change from Xylem’s previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. Xylem’s payout ratio is 43.88%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on XYL shares. Royal Bank Of Canada dropped their target price on Xylem from $176.00 to $162.00 and set an “outperform” rating for the company in a report on Wednesday, February 11th. Oppenheimer set a $165.00 price objective on Xylem in a research report on Thursday, February 12th. Stifel Nicolaus dropped their price objective on Xylem from $178.00 to $175.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Finally, William Blair assumed coverage on shares of Xylem in a research note on Monday, January 26th. They issued an “outperform” rating on the stock. Nine equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $158.08.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.